Scott M. Wasserman
Chief Medical Officer · Kailera Therapeutics, Inc.
Individual
- 2026
- Apr 20, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Scott M. Wasserman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BAIN CAPITAL INVESTORS LLC - $134.38M in KLRA purchases and sales in the last 12 months
- Andrew T. Kaplan - $134.38M in KLRA purchases and sales in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $25.00M in KLRA purchases and sales in the last 12 months
- Adam Koppel - $25.00M in KLRA purchases and sales in the last 12 months
- RTW INVESTMENTS, LP - $8.00M in KLRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Scott M. Wasserman?
Scott M. Wasserman is a corporate insider, tracked as Chief Medical Officer of Kailera Therapeutics, Inc. (KLRA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Scott M. Wasserman last file a Form 4?
The only primary Form 4 on record is dated 20 April 2026.